Oxazolidinone Resistance Mediated by

Adult Anti-Bacterial Agents / pharmacology Austria / epidemiology Drug Resistance, Bacterial / genetics Enterococcus faecalis / drug effects Female Genes, Bacterial Humans Linezolid / pharmacology Male Microbial Sensitivity Tests Middle Aged Oxazolidinones / pharmacology Plasmids RNA, Ribosomal, 23S / genetics Retrospective Studies Whole Genome Sequencing

Austria Enterococcus faecalis PCR linezolid optrA whole genome sequencing

Journal

Microbial drug resistance (Larchmont, N.Y.)

ISSN: 1931-8448

Titre abrégé: Microb Drug Resist

Pays: United States

ID NLM: 9508567

Informations de publication

Date de publication:
May 2021

Historique:

pubmed: 23 10 2020

medline: 16 11 2021

entrez: 22 10 2020

Statut: ppublish

Résumé

The genetic mechanisms associated with acquisition of linezolid (LZD) resistance are diverse, including point mutations in the V domain of the 23S rRNA and the 50S ribosomal proteins as well as

Identifiants

DOI: 10.1089/mdr.2020.0098 PMID: 33090061

pubmed: 33090061

doi: 10.1089/mdr.2020.0098

doi:

Substances chimiques

Anti-Bacterial Agents 0

Oxazolidinones 0

RNA, Ribosomal, 23S 0

Linezolid ISQ9I6J12J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

685-690

Auteurs

Heidrun Kerschner (H)

National Reference Center for Antimicrobial Resistance and Nosocomial Infections (NRZ), Institute for Hygiene, Microbiology and Tropical Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria.

Adriana Cabal Rosel (AC)

AGES-Austrian Agency for Health and Food Safety, Institute of Medical Microbiology and Hygiene, Vienna, Austria.

Rainer Hartl (R)

National Reference Center for Antimicrobial Resistance and Nosocomial Infections (NRZ), Institute for Hygiene, Microbiology and Tropical Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria.

Patrick Hyden (P)

CUBE, Division of Computational Systems Biology, University of Vienna, Vienna, Austria.

Anna Stoeger (A)

AGES-Austrian Agency for Health and Food Safety, Institute of Medical Microbiology and Hygiene, Vienna, Austria.

Werner Ruppitsch (W)

AGES-Austrian Agency for Health and Food Safety, Institute of Medical Microbiology and Hygiene, Vienna, Austria.

Franz Allerberger (F)

AGES-Austrian Agency for Health and Food Safety, Institute of Medical Microbiology and Hygiene, Vienna, Austria.

Petra Apfalter (P)

National Reference Center for Antimicrobial Resistance and Nosocomial Infections (NRZ), Institute for Hygiene, Microbiology and Tropical Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen

1.00

Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.

1.00

Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.

1.00

Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.

1.00

Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Régions géographiques › Europe › Autriche › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Enterococcus faecalis › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Génome microbien › Génome bactérien › Gènes bactériens › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Oxazoles › Oxazolidinones › Linézolide › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Oxazoles › Oxazolidinones › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN ribosomique › ARN ribosomique 23S › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Oxazolidinone Resistance Mediated by

questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Séquençage du génome entier › Oxazolidinone Resistance Mediated by